Skip to main content
SpringerLink
Log in

Adalimumab

Mucosal leishmaniasis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Duailibi DF, et al. TERAPIA PROFILATICA COM ANFOTERICINA B LIPOSSOMAL NA RECORRENCIA DA LEISHMANIOSE MUCOCUTANEA. RELATO DE EXPERIENCIA BEM-SUCEDIDA EM PACIENTE PORTADOR DE ESPONDILITE ANQUILOSANTE PRIMARIA EM USO DE ANTI-TNF. Brazilian Journal of Infectious Diseases 22 (Suppl. 1): 51-52 abstr. EP-035, Dec 2018. Available from: URL: http://doi.org/10.1016/j.bjid.2018.10.097 [abstract] -Brazil

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1734, 16 (2019). https://doi.org/10.1007/s40278-019-56142-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-56142-9

Search

Navigation